Dadonienė J, Charukevič G, Jasionytė G, Staškuvienė K, Miltinienė D (2021) Mortality in inflammatory rheumatic diseases: lithuanian national registry data and systematic review. Int J Environ Res Public Health 18(23):12338

Article  PubMed  PubMed Central  Google Scholar 

Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 41(2):243–256

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsunaga M, Lim E, Davis J, Chen JJ (2021) Dietary quality associated with self-reported diabetes, osteoarthritis, and rheumatoid arthritis among younger and older US adults: a cross-sectional study using NHANES 2011–2016. Nutrients 13(2):545

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong R, Sun L, Li H, Wang D (2022) The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease. Autoimmunity 55(1):1–7

Article  CAS  PubMed  Google Scholar 

Ding S, Xu S, Ma Y, Liu G, Jang H, Fang J (2019) Modulatory mechanisms of the NLRP3 inflammasomes in diabetes. Biomolecules 9(12):850

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehta P, Gasparyan AY, Zimba O, Kitas GD, Yessirkepov M (2022) Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses. Clin Rheumatol 41(12):3897–3913

Article  PubMed  PubMed Central  Google Scholar 

Szabłowski M, Okruszko MA, Pochodowicz K, Abramowicz P, Konstantynowicz J, Bossowski A et al (2022) Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review. Rheumatol Int 42(2):371–378

Article  PubMed  PubMed Central  Google Scholar 

Pablos JL, Galindo M, Carmona L, Lledó A, Retuerto M, Blanco R et al (2020) Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis 79(12):1544–1549

Article  CAS  PubMed  Google Scholar 

Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417

Article  PubMed  Google Scholar 

Nicolau J, Lequerré T, Bacquet H, Vittecoq O (2017) Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine 84(4):411–416

Article  CAS  PubMed  Google Scholar 

Xie W, Yang X, Ji L, Zhang Z (2020) Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50(4):598–607

Article  CAS  PubMed  Google Scholar 

Cacciapaglia F, Spinelli FR, Bartoloni E, Bugatti S, Erre GL, Fornaro M et al (2023) Clinical features of diabetes mellitus on rheumatoid arthritis: data from the cardiovascular obesity and rheumatic disease (CORDIS) study group. J Clin Med 12(6):2148

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roberts MJ, Leonard AN, Bishop NC, Moorthy A (2022) Lifestyle modification and inflammation in people with axial spondyloarthropathy-A scoping review. Musculoskeletal Care 20(3):516–528

Article  PubMed  Google Scholar 

Emamifar A, Jensen Hansen IM (2018) The influence of thyroid diseases, diabetes mellitus, primary hyperparathyroidism, vitamin B12 deficiency and other comorbid autoimmune diseases on treatment outcome in patients with rheumatoid arthritis: an exploratory cohort study. Medicine (Baltimore) 97(21):e10865

Article  CAS  PubMed  Google Scholar 

Li W, Bi S, Liang Y, Zhu H (2022) Construction of rheumatoid arthritis risk prediction and medical image applications from rheumatoid factor levels. Comput Math Methods Med 2022:8617467

Article  PubMed  PubMed Central  Google Scholar 

Emamifar A, Levin K, Jensen Hansen IM (2017) Patients with newly diagnosed rheumatoid arthritis are at increased risk of diabetes mellitus: an observational cohort study. Acta Reumatol Port 42(4):310–317

PubMed  Google Scholar 

Panopoulos S, Tektonidou M, Drosos AA, Liossis SN, Dimitroulas T, Garyfallos A et al (2018) Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study. Arthritis Res Ther 20(1):267

Article  PubMed  PubMed Central  Google Scholar 

Cacciapaglia F, Spinelli FR, Piga M, Erre GL, Sakellariou G, Manfredi A et al (2022) Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: data from the cardiovascular obesity and rheumatic disease (CORDIS) study group. Eur J Intern Med 96:60–65

Article  CAS  PubMed  Google Scholar 

Avouac J, Elhai M, Forien M, Sellam J, Eymard F, Molto A et al (2021) Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetes. Rheumatology (Oxford) 60(8):3598–3606

Article  CAS  PubMed  Google Scholar 

Arias de la Rosa I, Escudero-Contreras A, Rodríguez-Cuenca S, Ruiz-Ponce M, Jiménez-Gómez Y, Ruiz-Limón P et al (2018) Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues. J Intern Med 284(1):61–77

Article  CAS  PubMed  Google Scholar 

Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Margiotta DPE et al (2021) Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study. Clin Exp Rheumatol 39(5):995–1002

Article  PubMed  Google Scholar 

Ruscitti P, Ursini F, Cipriani P, Ciccia F, Liakouli V, Carubbi F et al (2017) Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: results from a cross-sectional study. Medicine (Baltimore) 96(34):e7896

Article  CAS  PubMed  Google Scholar 

Eddy Warman N, Baharuddin H, Abdul Rahman TH, Ismail N, Ch’Ng SS, Rosman A, Abdul Ghani R (2022) High prevalence of undiagnosed impaired glucose tolerance in patients with rheumatoid arthritis. SAGE Open Med 10:20503121221088090

Article  PubMed  Google Scholar 

Al-Sari UA (2022) Rheumatoid arthritis as a predisposing factor for increased risk of diabetes mellitus incidence. Wiad Lek 75(10):2329–2333. https://doi.org/10.36740/WLek202210103

Article  PubMed  Google Scholar 

Li G, Chi W, Bai B, Li Y, Wei T, Fu L (2019) Dose−response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case−control study. BMJ Open 9(7):e028011

Article  PubMed  PubMed Central  Google Scholar 

Thomas K, Lazarini A, Kaltsonoudis E, Drosos A, Papalopoulos I, Sidiropoulos P et al (2018) Multicenter cross-sectional study of patients with rheumatoid arthritis in Greece: results from a cohort of 2.491 patients. Mediterr J Rheumatol 29(1):27–37

Article  PubMed  PubMed Central  Google Scholar 

Di Muzio C, Cipriani P, Ruscitti P (2022) Rheumatoid arthritis treatment options and type 2 diabetes: unravelling the association. BioDrugs 36(6):673–685

Article  PubMed  PubMed Central  Google Scholar 

Paul SK, Montvida O, Best JH, Gale S, Pethö-Schramm A, Sarsour K (2021) Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis. BMJ Open 11(6):e042246

Article  PubMed  PubMed Central  Google Scholar 

Lurati A, Laria A, Mazzocchi D, Re KA, Marrazza MG, Faggioli PM et al (2021) Improvement of HbA1c in patients with type 2 diabetes mellitus and rheumatoid arthritis treated with bDMARDs. Open Access Rheumatol 13:73–78

Article  PubMed  PubMed Central  Google Scholar 

Desai RJ, Dejene S, Jin Y, Liu J, Kim SC (2020) Comparative risk of diabetes mellitus in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying drugs: a cohort study. ACR Open Rheumatol 2(4):222–231

Article  PubMed  PubMed Central  Google Scholar 

Lin C, Ji H, Cai X, Yang W, Lv F, Ji L (2020) The association between the biological disease-modifying anti-rheumatic drugs and the incidence of diabetes: a systematic review and meta-analysis. Pharmacol Res 161:105216

Article  CAS  PubMed  Google Scholar 

Nam SH, Kim M, Kim YJ, Ahn SM, Hong S, Lee CK et al (2022) Risk of new-onset diabetes mellitus associated with antirheumatic drugs in patients with rheumatoid arthritis: a nationwide population study. J Clin Med 11(8):2109

Article  CAS  PubMed  PubMed Central  Google Scholar 

Youssef J, Novosad SA, Winthrop KL (2015) Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am 42(1):157–176

Article  PubMed  PubMed Central  Google Scholar 

Movahedi M, Beauchamp ME, Abrahamowicz M, Ray DW, Michaud K, Pedro S et al (2016) Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis. Arthritis Rheumatol 68(5):1089–1098

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lillegraven S, Greenberg JD, Reed GW, Saunders K, Curtis JR, Harrold L et al (2019) Immunosuppressive treatment and the risk of diabetes in rheu